A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer (Q45141064)
Jump to navigation
Jump to search
scientific article published in January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer |
scientific article published in January 2005 |
Statements
1 reference
A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer (English)
1 reference
Francesco Caponigro
1 reference
Pax Willemse
1 reference
Roberto Sorio
1 reference
Anne Floquet
1 reference
Simon van Belle
1 reference
Jan Demol
1 reference
Rosa Tambaro
1 reference
Alessandro Comandini
1 reference
Angela Capriati
1 reference
Sabine Adank
1 reference
Jantien Wanders
1 reference
1 January 2005
1 reference
1 reference
23
1 reference
1
1 reference
85-89
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference